Minimizing antimicrobial resistance in hospital bacteria: can switching or cycling drugs help? (Q39751829)

14 September 2017

1 reference

title

Minimizing antimicrobial resistance in hospital bacteria: can switching or cycling drugs help? (English)

1 reference

14 September 2017

McGowan JE Jr

1

1 reference

14 September 2017

1 December 1986

1 reference

14 September 2017

1 reference

14 September 2017

7

1 reference

14 September 2017

12

1 reference

14 September 2017

573-576

1 reference

Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis

14 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Prevalence of extrachromosomal drug resistance. The role of drug-resistant and drug-selected bacteria in nosocomial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Frequency of aminoglycoside 6'-N-acetyltransferase among Serratia species during increased use of amikacin in the hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Hospital distribution, persistence, and reintroduction of related gentamicin R plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Future trends in aminoglycoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Comparison of antibiotic resistance of gram-negative bacilli with beta-lactam and aminoglycoside antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Instability of antibiotic resistance in a strain of Staphylococcus epidermidis isolated from an outbreak of prosthetic valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Trends in bacterial susceptibility to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Characteristics of gentamicin resistance in nosocomial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Conjugative R plasmids in antimicrobial resistance of Staphylococcus aureus causing nosocomial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Antibiotic resistance patterns during aminoglycoside restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Antimicrobial activity, bacterial resistance, and antimicrobial pharmacology. Is it possible to use new agents cost-effectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Five-year surveillance of aminoglycoside usage in a university hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

Cost-effectiveness of antibiotic use

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Predicting gentamicin resistance from annual usage in hospital

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Empiric use of aminoglycosides in hospitals.

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Prevalence and mechanisms of aminoglycoside resistance. A ten-year study

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Review of epidemic aminoglycoside resistance worldwide

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Treatment of pediatric infections with amikacin as first-line aminoglycoside.

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Antibiotic resistance in intensive care unit areas

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Clinical and microbiologic consequences of amikacin use during a 42-month period

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Surveillance of aminoglycoside resistance. European data

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Restriction policies for therapy with combination antibiotics

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Aminoglycoside resistance: a worldwide perspective.

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

Strategies in aminoglycoside use and impact upon resistance.

1 reference

https://api.crossref.org/works/10.1017%2FS0195941700065401

7 January 2021

10.1017/S0195941700065401

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

3539850